Cargando…

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201

Detalles Bibliográficos
Autores principales:	Philla, Katherine Q., Bauer, Andrew J., Vogt, Karen S., Greeley, Siri Atma W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392914/ http://dx.doi.org/10.2337/dc14-er02b

Ejemplares similares

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation
por: Philla, Katherine Q., et al.
Publicado: (2013)

Erratum. Cardiometabolic Risk in a Rural Ugandan Population. Diabetes Care 2013;36;e143
por: Murphy, Georgina A.V., et al.
Publicado: (2017)

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
por: Schernthaner, G, et al.
Publicado: (2013)

Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 2013;36(Suppl. 2):S226–S232
por: Vora, J
Publicado: (2013)

Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes. Diabetes Care 2013;36:450–456
por: Danielson, Kirstie K., et al.
Publicado: (2014)

Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
por: Shah, Reshma P., et al.
Publicado: (2012)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma: erratum
Publicado: (2017)

SUN-143 Does a Monogenic Diabetes Diagnosis Impact Quality of Life?
por: Harris, Anastasia, et al.
Publicado: (2019)

Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–1046
Publicado: (2013)

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
por: Morbach, Stephan, et al.
Publicado: (2013)

Acute Recurrent Pancreatitis in a Child With INS-Related Monogenic Diabetes and a Heterozygous Pathogenic CFTR Mutation
por: Son, Rachel G, et al.
Publicado: (2022)

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201
por: Chaudhary, Sandeep, et al.
Publicado: (2013)

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes
por: Dalgin, Gokhan, et al.
Publicado: (2021)

ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents
por: Greeley, Siri Atma W., et al.
Publicado: (2022)

Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987
por: Moore, EM, et al.
Publicado: (2013)

Response to Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201
por: Shields, Beverley M., et al.
Publicado: (2013)

SAT083 Comparing Grit, Anxiety, And Social Responsiveness In KCNJ11-NDM And Their Sibling Controls
por: Desai, Jui, et al.
Publicado: (2023)

Management of sulfonylurea‐treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer
por: Shepherd, M., et al.
Publicado: (2017)

Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
por: Riddle, Matthew C., et al.
Publicado: (2020)

Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
por: Jiang, Luohua, et al.
Publicado: (2014)

Inheritance of Mildly Activating ABCC8 Mutation From a Mother With MODY Causes Permanent Neonatal Diabetes Mellitus (NDM) in Two Siblings Who Also Carry a Second Inactivating Mutation: Genetic Testing Allows for Improved Treatment With Sulfonylureas (SU)
por: Salguero Bermonth, Maria Victoria, et al.
Publicado: (2021)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects. Diabetes 2013;62:2752–2756
por: Sathananthan, M, et al.
Publicado: (2013)

Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. Diabetes Care 2013;36:1827–1833
por: Gordin, D, et al.
Publicado: (2013)

Response to Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
por: Knowler, William C., et al.
Publicado: (2014)

Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
por: Bowden, Tiana L., et al.
Publicado: (2021)

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
por: Weil, E. Jennifer, et al.
Publicado: (2018)

Sulfonylurea for the treatment of neonatal diabetes owing to K(ATP)-channel mutations: a systematic review and meta-analysis
por: Zhang, Hongliang, et al.
Publicado: (2017)

Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 2013;36:1735–1741
Publicado: (2013)

Sulfonylurea Use During Entire Pregnancy in Diabetes Because of KCNJ11 Mutation: A Report of Two Cases
por: Gaal, Zsolt, et al.
Publicado: (2012)

Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation
por: Ahn, Sung Yeon, et al.
Publicado: (2015)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
por: Cho, Ja Hyang, et al.
Publicado: (2017)

Deer mouse hemoglobin exhibits a lowered oxygen affinity owing to mobility of the E helix. Corrigendum
por: Inoguchi, Noriko, et al.
Publicado: (2013)

Systematic Review of Treatment of Beta-Cell Monogenic Diabetes
por: Naylor, Rochelle N., et al.
Publicado: (2023)

Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
por: Goodarzi, Mark O.
Publicado: (2014)

Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406–1412
por: Hecking, Manfred, et al.
Publicado: (2013)

A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013;36:480–489
por: Kan, C, et al.
Publicado: (2013)

Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Lai, Shih-Wei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t62j1aqjduht26b0peehmrh6ek